Clinical and molecular characterization of patients with Gardner syndrome using whole exome sequencing

Egyptian Pharmaceutical Journal · Published 2025-09-18 · DOI 10.21608/epj.2025.399842.1136

Authors being retrieved — see the publisher record. https://doi.org/10.21608/epj.2025.399842.1136

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2025

Related articles

Wound healing activity of Centella asiatica extract via inflammatory gene regulation in zebrafish (Danio rerio) · Egyptian Pharmaceutical Journal · 2026 · Same journal
Phytase superior Lactobacillusisolate (L-Phy5) and its mutants: molecular identification · Egyptian Pharmaceutical Journal · 2025 · Same journal
Next-Generation Topical Nanosuspension of HMG-CoA Reductase Inhibitors: A Novel Dermatological Approach Against Aging and Inflammation · Egyptian Pharmaceutical Journal · 2026 · Same journal
N-Acetylcysteine ameliorates the dysfunction of submandibular glands in type 1 diabetic rats via modulation of NF-κB, Nrf2, Bcl-2, and Caspase-3 · Egyptian Pharmaceutical Journal · 2026 · Same journal
Synthesis, Characterization, and Antimicrobial Evaluation of a New Pyrazole-Oxadiazole Hybrid Derivatives · Egyptian Pharmaceutical Journal · 2026 · Same journal
Production of Exopolysaccharides by Diverse Bacterial Strains Isolated from Cheese Whey · Egyptian Pharmaceutical Journal · 2025 · Same journal
Ethanolic extract of Andrographis paniculata induces apoptosis and modulates autophagy in in lung cancer cells via the activation of reactive oxygen species formation: an in vitro study · Egyptian Pharmaceutical Journal · 2026 · Same journal
Expression of miR-15a-5p, miR-17-5p, and miR-103-3p in hypertension-associated chronic kidney disease and hemodialysis patients · Egyptian Pharmaceutical Journal · 2025 · Same journal
Pharmacological enhancement of Ocimum secondary metabolites via Spirulina extract: A molecular perspective · Egyptian Pharmaceutical Journal · 2026 · Same journal
Computational investigation of daphnoretin as a potential matrix metalloproteinase-1 inhibitor: molecular docking, MM-GBSA, and molecular dynamics study · Egyptian Pharmaceutical Journal · 2026 · Same journal